SAT0299 Apremilast: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials in patients with Psoriatic Arthritis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.2024 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A685.1-A685 ◽

Author(s):

P. J. Mease ◽

A. Kavanaugh ◽

A. O. Adebajo ◽

J. J. Gomez-Reino ◽

J. Wollenhaupt ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Randomized Controlled Trials ◽

Safety Analysis ◽

Controlled Trials ◽

Phase 3 ◽

Randomized Controlled ◽

Download Full-text

SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.5589 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 742.2-743 ◽

Author(s):

P.J. Mease ◽

A. Kavanaugh ◽

D. Gladman ◽

A.O. Adebajo ◽

J.J. Gomez-Reino ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Randomized Controlled Trials ◽

Safety Analysis ◽

Controlled Trials ◽

Phase 3 ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Three Phase ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

Long‐Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials

ACR Open Rheumatology ◽

10.1002/acr2.11156 ◽

2020 ◽

Author(s):

Philip J. Mease ◽

Dafna D. Gladman ◽

Juan J. Gomez‐Reino ◽

Stephen Hall ◽

Arthur Kavanaugh ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Randomized Controlled Trials ◽

Safety Analysis ◽

Phase Iii ◽

Controlled Trials ◽

Randomized Controlled ◽

Download Full-text

THU0432 Long-Term (104-Week) Safety Profile of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.3582 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 355.3-356 ◽

Author(s):

P. Mease ◽

A. Adebajo ◽

D. Gladman ◽

J. Gomez-Reino ◽

S. Hall ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Randomized Controlled Trials ◽

Safety Profile ◽

Controlled Trials ◽

Phase 3 ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Three Phase ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

OP0169 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase 3, Randomized, Controlled Trials

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.3594 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 133-134 ◽

Author(s):

D. Gladman ◽

A. Kavanaugh ◽

A. Adebajo ◽

J. Gomez-Reino ◽

J. Wollenhaupt ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Phase 3 ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Three Phase ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

SAT0579 Secukinumab Safety and Tolerability in Patients with Active Psoriatic Arthritis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials (Future 1 and Future 2)

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.3112 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 870.3-871

Author(s):

P. Mease ◽

I.B. McInnes ◽

H. Richards ◽

L. Pricop ◽

A. Widmer ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Randomized Controlled Trials ◽

Safety Analysis ◽

Controlled Trials ◽

Phase 3 ◽

Two Phase ◽

Randomized Controlled ◽

Download Full-text

FRI0470 Long-Term (156-Week) Safety Profile of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of 3 Phase III, Randomized, Controlled Trials

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3265 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 608.1-608

Author(s):

P.J. Mease ◽

D.D. Gladman ◽

J.J. Gomez-Reino ◽

S. Hall ◽

A. Kavanaugh ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Randomized Controlled Trials ◽

Safety Profile ◽

Safety Analysis ◽

Phase Iii ◽

Controlled Trials ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

Safety of 1 L Polyethylene Glycol-Based Bowel Preparation, NER1006, for Colon Cleansing Before Colonoscopy: A Pooled Analysis of Three Phase 3 Randomized Controlled Trials

The American Journal of Gastroenterology ◽

10.14309/00000434-201810001-00506 ◽

2018 ◽

Vol 113 (Supplement) ◽

pp. S290-S291

Author(s):

Neal Osborn ◽

Howard Franklin ◽

Prateek Sharma

Keyword(s):

Polyethylene Glycol ◽

Randomized Controlled Trials ◽

Bowel Preparation ◽

Pooled Analysis ◽

Controlled Trials ◽

Phase 3 ◽

Colon Cleansing ◽

Randomized Controlled ◽

Download Full-text

O03 Apremilast, an Oral Phosphodiesterase-4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials

Rheumatology ◽

10.1093/rheumatology/kew122.002 ◽

2016 ◽

Keyword(s):

Psoriatic Arthritis ◽

Randomized Controlled Trials ◽

Phase Iii ◽

Controlled Trials ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Three Phase ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

OP0078 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-WEEK) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.1827 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 90.2-91 ◽

Author(s):

A. Kavanaugh ◽

M. Cutolo ◽

P. Mease ◽

D. Gladman ◽

A. Adebajo ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Disease Activity ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Phase 3 ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

194 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104 Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials

Rheumatology ◽

10.1093/rheumatology/kew145.005 ◽

2016 ◽

Keyword(s):

Psoriatic Arthritis ◽

Randomized Controlled Trials ◽

Phase Iii ◽

Controlled Trials ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Three Phase ◽

Phosphodiesterase 4 Inhibitor

Download Full-text